The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain

Biochemical and Biophysical Research Communications

Volumn 273, Issue 1, 2000, Pages 203-208

  Chang, Shin Wen ^a   Zhang, Dekui ^a   Chung, Hyung Doo ^b   Zassenhaus, H Peter ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Brain; Mitochondrial DNA; Mutations

Indexed keywords

MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DELETION MUTANT; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PARIETAL LOBE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0034709595     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2885     Document Type: Article

References (34)

1. Markesbery W. R. The role of oxidative stress in Alzheimer disease. Arch. Neurol. 56:1999;1449-1452.
2. Mecocci P., MacGarvey U., Beal M. F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
3. Feig D. I., Reid T. M., Loeb L. A. Reactive oxygen species in tumorigenesis. Cancer Res. 54:1994;1890s-1894s.
4. Gross N. J., Getz G. S., Rabinowitz M. Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissues of the rat. J. Biol. Chem. 244:1969;1552-1562.
5. Menzies R. A., Gold P. H. The apparent turnover of mitochondria, ribosomes and sRNA of the brain in young adult and aged rats. J. Neurochem. 19:1972;1671-1683.
6. Bonilla E., Tanji K., Hirano M., Vu T. H., DiMauro S., Schon E. A. Mitochondrial involvement in Alzheimer's disease. Biochim. Biophys. Acta. 1410:1999;171-182.
7. Smith T. S., Bennett J. P. Jr. Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res. Mol. Brain Res. 765:1997;183-188.
8. Cortopassi G. A., Shibata D., Soong N. W., Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA. 89:1992;7370-7374.
9. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
10. Forster E. An improved general method to generate internal standards for competitive PCR. Biotechniques. 16:1994;18-20.
11. Linnane A. W., Baumer A., Maxwell R. J., Preston H., Zhang C. F., Marzuki S. Mitochondrial gene mutation: The ageing process and degenerative diseases. Biochem. Int. 22:1990;1067-1076.
12. Bouaboula M., Legoux P., Pessegue B., Delpech B., Dumont X., Piechaczyk M., Casellas P., Shire D. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J. Biol. Chem. 267:1992;21830-21838.
13. Kadenbach B., Munscher C., Frank V., Muller-Hocker J., Napiwotzki J. Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutat. Res. 338:1995;161-172.
14. Corral-Debrinski M., Horton T., Lott M. T., Shoffner J. M., Beal M. F., Wallace D. C. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat. Genet. 2:1992;324-329.
15. Soong N. W., Hinton D. R., Cortopassi G., Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat. Genet. 2:1992;318-323.
16. Corral-Debrinski M., Horton T., Lott M. T., Shoffner J. M., McKee A. C., Beal M. F., Graham B. H., Wallace D. C. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics. 23:1994;471-476.
17. Ikebe S., Tanaka M., Ohno K., Sato W., Hattori K., Kondo T., Mizuno Y., Ozawa T. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem. Biophys. Res. Commun. 170:1990;1044-1048.
18. Simonetti S., Chen X., DiMauro S., Schon E. A. Accumulation of deletions in human mitochondrial DNA during normal aging: Analysis by quantitative PCR. Biochim. Biophys. Acta. 1180:1992;113-122.
19. Parker W. D. Jr. Cytochrome oxidase deficiency in Alzheimer's disease. Ann. N.Y. Acad. Sci. 640:1991;59-64.
20. Blass J. P., Gibson G. E. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. (Paris). 147:1991;513-525.
21. Peterson C., Goldman J. E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA. 83:1986;2758-2762.
22. Blass J. P., Gibson G. E. Nonneural markers in Alzheimer disease. Alzheimer Dis. Assoc. Disorders. 6:1992;205-224.
23. Ito E., Oka K., Etcheberrigaray R., Nelson T. J., McPhie D. L., Tofel-Grehl B., Gibson G. E., Alkon D. L. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;534-538.
24. Etcheberrigaray R., Ito E., Oka K., Tofel-Grehl B., Gibson G. E., Alkon D. L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8209-8213.
25. Yen T. C., Su J. H., King K. L., Wei Y. H. Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochem. Biophys. Res. Commun. 178:1991;124-131.
26. Stoneking M., Hedgecock D., Higuchi R. G., Vigilant L., Erlich H. A. Population variation of human mtDNA control region sequences detected by enzymatic amplification and sequence-specific oligonucleotide probes. Am. J. Hum. Genet. 48:1991;370-382.
27. Lezza A. M., Mecocci P., Cormio A., Beal M. F., Cherubini A., Cantatore P., Senin U., Gadaleta M. N. Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients. FASEB J. 13:1999;1083-1088.
28. Shibutani S., Takeshita M., Grollman A. P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 349:1991;431-434.
29. Chandrasekaran K., Hatanpaa K., Brady D. R., Rapoport S. I. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp. Neurol. 142:1996;80-88.
30. Blanchard B. J., Park T., Fripp W. J., Lerman L. S., Ingram V. M. A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue. Neuroreport. 4:1993;799-802.
31. Cavelier L., Jazin E. E., Eriksson I., Prince J., Bave U., Oreland L., Gyllensten U. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics. 29:1995;217-224.
32. Shoubridge E. A., Karpati G., Hastings K. E. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell. 62:1990;43-49.
33. Liu V. W., Zhang C., Nagley P. Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. Nucleic Acids Res. 26:1998;1268-1275.
34. Pallotti F., Chen X., Bonilla E., Schon E. A. Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. Am. J. Hum. Genet. 59:1996;591-602.